XML 92 R82.htm IDEA: XBRL DOCUMENT v3.20.2
Derivative Instruments and Hedging Activities - Impact and Location of Derivative Instruments for Derivatives Designated as Cash Flow Hedging and the Related Components Excluded From Effectiveness Testing (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2020
Aug. 02, 2019
Jul. 31, 2020
Aug. 02, 2019
Derivative Instruments, Gain (Loss) [Line Items]        
Net sales $ 840,972 $ 838,713 $ 2,537,853 $ 2,403,705
Cost of Sales (546,398) (572,732) (1,648,474) (1,600,809)
Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of gain reclassified from AOCL into earnings 1,953 1,490 5,970 4,325
Net Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Net sales 840,972 838,713 2,537,853 2,403,705
Cost of Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Cost of Sales (546,398) (572,732) (1,648,474) (1,600,809)
Forward currency contracts | Net Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of gain reclassified from AOCL into earnings 1,795 1,350 5,272 3,828
Gain on components excluded from effectiveness testing recognized in earnings based on changes in fair value 191 1,262 3,183 3,579
Forward currency contracts | Cost of Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of gain reclassified from AOCL into earnings 158 140 698 497
Gain on components excluded from effectiveness testing recognized in earnings based on changes in fair value $ 86 $ 18 $ 231 $ 34